Evaluation of Safety and Efficacy of Intravenous Sulbactam-ETX2514 in the Treatment of Hospitalized Adults With Complicated Urinary Tract Infections
Clinical trial NCT03445195 · COMPLETED
Trial details
- NCT number
- NCT03445195
- Sponsor
- Entasis Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-17
- Primary completion
- 2018-05-17
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.